2013 Media Kit
ASCP 2013 Chicago, Sept. 18–21, at the Hyatt Regency Chicago, will convene the foremost experts and peers in pathology and laboratory medicine to share their latest scientific discoveries and insights on how the medical laboratory profession can improve patient-centered care around the globe.
ASCP 2013 Chicago packs an energizing array of more than 180 education sessions into four days. Media are welcome to attend the educational sessions and explore hundreds of scientific research and medical laboratory management abstracts highlighting new technologies, techniques, advances in clinical and anatomical pathology, and more.
Three general sessions at this year’s Annual Meeting underscore the overarching theme, “Beyond the Lab.”
Also, Chris Hansen will present “Perspectives on the Supreme Court Gene Patent Ruling” from 2 to 2:50 p.m. on Sept. 18. Mr. Hansen represented the ACLU, ASCP, and 19 other plaintiffs in the lawsuit against Myriad Genetics, Inc., whose patent on BRCA1 and BRCA2—gene alterations associated with an increased risk for breast and ovarian cancer—was overturned by the U.S. Supreme Court in June.
Visit the Daily Session Finder to learn more about individual sessions and presenters.
Other Hot Topics at this year’s meeting include:
- Choosing Wisely & Appropriate Test Utilization
- Pathology Informatics
- Genomics and Personalized Medicine
- Trends in Telepathology, Telecytology and Digital Imaging
- ACOs, the Affordable Care Act and Patient-centered Care
- Global Health & Strategies for Building a Sustainable Global Laboratory Workforce
Stay current with the ASCP 2013 Mobile App, and find out what fellow followers are saying about ASCP 2013 Chicago by using #ascp2013:
Download the ASCP 2013 App:
Please contact Sarah Minnis (email@example.com, 312.558.1770 ext. 161) or Colleen Correll (firstname.lastname@example.org, 312.558.1770 ext. 145) to set up interviews with presenters and study authors. Study abstracts will be available upon request. We encourage you to call or email us at any time with questions or requests. Please view the Policies and Guidelines for News Media for more information.